Detalhe da pesquisa
1.
Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4+ T cells allows complex functional analyses.
Nat Methods
; 19(1): 81-89, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34949807
2.
MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells.
PLoS Genet
; 17(12): e1009951, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871319
3.
Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAs.
Angew Chem Int Ed Engl
; 61(38): e202204556, 2022 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802496
4.
Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.
J Virol
; 91(13)2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424281
5.
NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.
Proc Natl Acad Sci U S A
; 112(11): E1333-42, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25739961
6.
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
J Virol
; 89(2): 970-88, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25355891
7.
Modification of promoter spacer length in vaccinia virus as a strategy to control the antigen expression.
J Gen Virol
; 96(8): 2360-2371, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25972354
8.
Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.
J Virol
; 87(12): 6955-74, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23596295
9.
Spatial resolution of HIV-1 post-entry steps in resting CD4 T cells.
Cell Rep
; 43(3): 113941, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478523
10.
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells.
Cell Rep Med
; 5(4): 101483, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579727
11.
New vaccinia virus promoter as a potential candidate for future vaccines.
J Gen Virol
; 94(Pt 12): 2771-2776, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24077296
12.
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.
Nat Med
; 28(3): 496-503, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090165
13.
Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection.
NPJ Vaccines
; 6(1): 52, 2021 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846352
14.
The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1.
Front Immunol
; 10: 2793, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31867001
15.
Development of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways.
Mol Ther Oncolytics
; 8: 27-40, 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367944
16.
A Prime/Boost PfCS14KM/MVA-sPfCSM Vaccination Protocol Generates Robust CD8+ T Cell and Antibody Responses to Plasmodium falciparum Circumsporozoite Protein and Protects Mice against Malaria.
Clin Vaccine Immunol
; 24(5)2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28298290
17.
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells.
Nat Commun
; 8: 16073, 2017 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28714465
18.
The evolution of poxvirus vaccines.
Viruses
; 7(4): 1726-803, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853483
19.
High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.
PLoS One
; 7(6): e38859, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715418